跳到正文
openFDA 已分级药品召回执法报告·· 26 天前精选AI 评分61

FDA 执法报告 D-0076-2027:Hikma 阿比特龙醋酸酯片批号 3047 因重量均匀度不合格列为 II 类召回

FDA drug enforcement D-0076-2027: Hikma Pharmaceuticals USA INC. — Failed Tablet/Capsule Specifications: Failed tablet specifications for weight uniformity.

AI 导读

openFDA 执法报告 D-0076-2027 显示,Hikma Pharmaceuticals USA 发起的阿比特龙醋酸酯(Abirtega)USP 250 mg 片剂召回被列为 II 类,原因是重量均匀度不符合片剂标准。

推荐理由

记录列出了阿比特龙醋酸酯片重量均匀度不合格召回的类别、批号与分销范围,便于核对批次追溯信息。

正文 · AI 翻译

FDA 药品召回执法报告 — D-0076-2027

报告发布日期:2026-10-28。这是执法报告日期,不是召回启动日期。

范围:一条已分类的药品召回记录;event_id 可能归组多个产品。没有召回编号的未分类记录不在本数据流范围内。本记录不是新闻稿,也不是新的执法认定。

openFDA 数据集每周更新。报告状态不是实时召回状态,不得用于跟踪召回生命周期。以下其他日期保留其各自名称所对应的含义。

完整官方产品记录(包括 openFDA 统一标识符):

{

"address_1": "1809 Wilson Rd",

"address_2": "",

"center_classification_date": "20261023",

"city": "Columbus",

"classification": "Class II",

"code_info": "批号:3047,有效期 2027 年 7 月。",

"country": "United States",

"distribution_pattern": "美国全国范围",

"event_id": "100046",

"initial_firm_notification": "Letter",

"more_code_info": "",

"openfda": {

"application_number": [

"ANDA208339"

],

"brand_name": [

"ABIRTEGA"

],

"generic_name": [

"ABIRATERONE ACETATE"

],

"is_original_packager": [

true

],

"manufacturer_name": [

"CivicaScript, LLC"

],

"package_ndc": [

"82249-011-12"

],

"product_ndc": [

"82249-011"

],

"product_type": [

"HUMAN PRESCRIPTION DRUG"

],

"route": [

"ORAL"

],

"rxcui": [

"1100075",

"2702601"

],

"spl_id": [

"692d596d-5465-4611-82f7-5d50c37270a2"

],

"spl_set_id": [

"2f932015-28b2-4f44-ac04-772e982e13e9"

],

"substance_name": [

"ABIRATERONE ACETATE"

],

"unii": [

"EM5OCB9YJ6"

],

"upc": [

"0382249011123"

]

},

"postal_code": "43228-9579",

"product_description": "Abirtega(醋酸阿比特龙)USP,250 mg,120 片装瓶,处方药,处方药,生产商:Hikma Pharmaceuticals USA Inc.,Berkley Heights, NJ 07922 USA;由 Arab Pharmaceuticals Manufacturing PSC 生产,PO Box 41, Sahab-Jordon,NDC 82249-011-12。",

"product_quantity": "2136 瓶",

"product_type": "Drugs",

"reason_for_recall": "片剂/胶囊规格不合格:片剂重量均一性规格不合格。",

"recall_initiation_date": "20261006",

"recall_number": "D-0076-2027",

"recalling_firm": "Hikma Pharmaceuticals USA INC.",

"report_date": "20261028",

"state": "OH",

"status": "Ongoing",

"voluntary_mandated": "Voluntary: Firm initiated"

}

来源:openFDA 已分级药品召回执法报告 · api.fda.gov